New Delhi, March 8 -- The maximum retail price (MRP) of 390 non-scheduled cancer medicines have been reduced by up to 87%, the government said Friday, days after India's drug pricing regulator brought 42 non-scheduled cancer drugs under price control-capping their trade margin at 30%. The move would result in annual savings of around Rs.800 crore for patients, the government said....